Zoe completed her MD at UCSF and her MS in Health and Medical Sciences at UC Berkeley. She completed her residency training in Internal Medicine at Stanford Hospital and Clinics prior to returning to UCSF for her Endocrinology and Diabetes for fellowship. Her research focus is in endocrine immune related adverse events following cancer immunotherapy. She is a recipient of the American Diabetes Association Postdoctoral Fellowship.
Zoe enjoys outdoor adventures and trying out hole-in-the wall restaurants
Immune receptors are surprisingly modular and can be mutated and composed to rewire cellular inputs and outputs, as showcased by the success of cell-based genetic therapies like Chimeric Antigen Receptor T-cell (CAR-T) therapy. My work involves high-throughput pooled screening of thousands of different synthetic receptors. A better understanding of the relationship between receptor sequence, signaling outcome, and cellular phenotype will lead to next-generation cell-based genetic therapies which manipulate the immune system to combat a variety of diseases.
A.W. and Mary Margaret Clausen Distinguished Professor
Director, Hormone Research Institute
Diabetes Center
Jeffrey Bluestone, PhD, is the A.W. and Mary Margaret Clausen Distinguished Professor of Metabolism and Endocrinology and is the Director of the Hormone Research Institute in the Diabetes Center. His research over the past 25 years has focused on understanding the basic processes that control T cell activation and immune tolerance in autoimmunity and organ transplantation.
